Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type-Reference-Cited by-同舟云学术

Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type

Published:2012-06-06 Issue:15 Volume:18 Page:4183-4190
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Ito Yoshinori,Kimura Hiroshi,Maeda Yoshinobu,Hashimoto Chizuko,Ishida Fumihiro,Izutsu Koji,Fukushima Noriyasu,Isobe Yasushi,Takizawa Jun,Hasegawa Yuichi,Kobayashi Hajime,Okamura Seiichi,Kobayashi Hikaru,Yamaguchi Motoko,Suzumiya Junji,Hyo Rie,Nakamura Shigeo,Kawa Keisei,Oshimi Kazuo,Suzuki Ritsuro

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance mechanisms and potential therapeutic strategies in relapsed or refractory natural killer/T cell lymphoma;Chinese Medical Journal;2024-08-23

2. First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial;The Lancet Haematology;2024-05

3. Aggressive T‐cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management;American Journal of Hematology;2024-02-02

4. Extranodal natural killer/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified;Journal of Clinical and Experimental Hematopathology;2024

5. Extranodal nasal-type NK/T lymphoma treated with chemotherapy and radiotherapy: case series from a European tertiary referral center and review of the literature;Strahlentherapie und Onkologie;2023-11-09